Clinical Validation of a Urine Test (Uromonitor-V2<sup>®</sup>) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients

Clinical Validation of a Urine Test (Uromonitor-V2<sup>®</sup>) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients

The costly and burdensome nature of the current follow-up methods in non-muscle-invasive bladder cancer (NMIBC) drives the development of new methods that may alternate with regular cystoscopy and urine cytology. The Uromonitor-V2<sup>®</sup> is a new urine-based assay in the detection o...

Full description

Bibliographic Details
Main Authors: Caroline A. Sieverink, Rui P. M. Batista, Hugo J. M. Prazeres, João Vinagre, Cristina Sampaio, Ricardo R. Leão, Valdemar Máximo, J. Alfred Witjes, Paula Soares
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Diagnostics
Subjects:
biomarkers
bladder cancer
cystoscopy
cytology
follow-up
non-muscle-invasive bladder cancer
Online Access:https://www.mdpi.com/2075-4418/10/10/745

Internet

https://www.mdpi.com/2075-4418/10/10/745

Similar Items